One MG single-arm CT reported a decrease in proteinuria with agalsidase beta when used in conjunction with antiproteinuric therapy (angiotensin-converting enzyme inhibitor [ACEi] and/or angiotensin receptor blocker [ARB]) [152]. This evidence concerns the gene ACE and myasthenia gravis.